Trastuzumab Lyophilised 150mg Vivitra

Trade Name:Vivitra

Manufacturer:Zydus Ingneia

Presentation: Injection


What is the Trastuzumab Lyophilised 150mg half life?

The half-life ofTrastuzumab Lyophilised 150mg is approximately 28.5 days, according to a retrospective review of population PK data for weekly trastuzumab using a two-compartment model,12 which supports less frequent dosing.

How is trastuzumab reconstituted?

DON’T SHIFT. Reconstitution: To create a multi-dose solution containing 21 mg/mL trastuzumab, combine each 440 mg vial of Herceptin with 20 mL of bacteriostatic water for injection (BWFI), USP, which contains 1.1% benzyl alcohol as a preservative.

What occurs after Herceptin therapy is over?

If you are of childbearing potential and receive Herceptin treatment, your doctor will advise you to avoid pregnancy for at least 7 months and have regular heart checks for at least 2 years because there is a higher risk of long-term heart damage in persons with this condition.

What are the negative effects of lyophilized Trastuzumab Lyophilised 150mg?

  • Fever
  • nausea
  • vomiting
  • infusion responses
  • diarrhoea, infections
  • increased cough
  • fatigue, dyspnea
  • rash
  • neutropenia
  • anaemia, and myalgia are the most frequent side effects in patients receiving Herceptin for adjuvant and metastatic breast cancer.

To know more click here

When should Trastuzumab Lyophilised 150mg be administered?

Most frequently, it is administered once every three weeks. Some folks might eat it every week. Although some patients are able to receive their treatment at home, you will often receive your treatment as an outpatient at the hospital. Because this is how it has been examined in clinical trials, trastuzumab is typically administered along with chemotherapy.

How is Trastuzumab Lyophilised 150mg administered?

Trastuzumab is administered via vein infusion (intravenous, IV). It takes 90 minutes to administer the first dose. Subsequent maintenance doses may be administered over a 30-minute period if well tolerated.

return if HER2 positive?

In comparison to HER2-negative breast cancer, HER2-positive breast cancer is more aggressive and more likely to return. Recurrence can occur at any time, but it often happens five years after therapy. The good news is that the likelihood of recurrence is lower than it has ever been.

What is the Trastuzumab Lyophilised 150mg success rate?

The disease-free survival rate was higher in women who were treated with Herceptin at 10 years after treatment: 73.7% of the women who got chemotherapy and Herceptin were still living without the cancer progressing. In 62.2% of the women who only got chemotherapy, the cancer did not spread.

How many months is trastuzumab therapy?

For individuals with early breast cancer that tests positive for HER2, adjuvant trastuzumab considerably improves outcomes. The typical course of treatment lasts for 12 months, although shorter courses could still be effective while posing less risks and costs.

We are a regular distributor, a supplier based in India, and an exporter with operations in more than five foreign countries, including the Myanmar, Indonesia, Qatar, Egypt, USA, etc. In the unlikely occasion if you’re looking for a product or brand, Click here.